General Gastro News Articles

Gastro

sponsor

Your Unread Messages

Hello, Suzanne Dixon
Manage E-mail  |  Logout
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Foroncewicz B et al. – A CS–free regimen of Tac/Dac is as effective as Tac/Cs in achieving good patient and graft survival. However, no substantial benefits insofar as the safety of Tac/Dac therapy were evident during long–term follow–up.


Today in Hepatology...keeping you current

Liver disease: Early signs you may be missing
APCToday, 10/21/09

Non-alcoholic fatty liver disease from pathogenesis to management: an update
Obesity Reviews, 11/02/09

Severe sepsis in cirrhosis
Hepatology, 11/04/09

Today in Pharmacology/kinetics...keeping you current

Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09

Safety Profile of IBD: Lymphoma Risks
Gastroenterology Clinics of North America, 11/16/09

Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Expert Opinion on Investigational Drugs, 10/26/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address